StemPoint Capital LP 13D/13G Filings for VistaGen Therapeutics, Inc. (VTGN)

StemPoint Capital LP 13D and 13G filings for VistaGen Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
1:01 pm
Purchase		 2024-12-31 13G VistaGen Therapeutics, Inc.
VTGN		 StemPoint Capital LP 2,328,492
8.200%		 538,310increase
(+30.07%)		 Filing
2024-02-12
6:27 pm
Purchase		 2023-12-31 13G VistaGen Therapeutics, Inc.
VTGN		 StemPoint Capital LP 1,790,182
6.500%		 1,790,182increase
(New Position)		 Filing